Prograf Maker Says Class Cert. Doesn't Clear 1st Circ.'s Bar
Astellas Pharma US LLC urged the First Circuit Wednesday to overturn class certification granted to indirect purchasers who claim the drugmaker delayed generic competition to Prograf, saying the judge shouldn't have...To view the full article, register now.
Already a subscriber? Click here to view full article